Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Early and Late Mortality Following Discharge From the ICU: A Multicenter Prospective Cohort Study.

Rosa RG, Falavigna M, Robinson CC, Sanchez EC, Kochhann R, Schneider D, Sganzerla D, Dietrich C, Barbosa MG, de Souza D, Rech GS, Dos Santos RDR, da Silva AP, Santos MM, Dal Lago P, Sharshar T, Bozza FA, Teixeira C; Quality of Life After ICU Study Group Investigators and the BRICNet.

Crit Care Med. 2019 Oct 11. doi: 10.1097/CCM.0000000000004024. [Epub ahead of print]

PMID:
31609775
2.

Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis.

Rebelatto TF, Falavigna M, Pozzari M, Spada F, Cella CA, Laffi A, Pellicori S, Fazio N.

Cancer Treat Rev. 2019 Sep 6;80:101895. doi: 10.1016/j.ctrv.2019.101895. [Epub ahead of print] Review.

PMID:
31542591
3.

Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit: The ICU Visits Randomized Clinical Trial.

Rosa RG, Falavigna M, da Silva DB, Sganzerla D, Santos MMS, Kochhann R, de Moura RM, Eugênio CS, Haack TDSR, Barbosa MG, Robinson CC, Schneider D, de Oliveira DM, Jeffman RW, Cavalcanti AB, Machado FR, Azevedo LCP, Salluh JIF, Pellegrini JAS, Moraes RB, Foernges RB, Torelly AP, Ayres LO, Duarte PAD, Lovato WJ, Sampaio PHS, de Oliveira Júnior LC, Paranhos JLDR, Dantas ADS, de Brito PIPGG, Paulo EAP, Gallindo MAC, Pilau J, Valentim HM, Meira Teles JM, Nobre V, Birriel DC, Corrêa E Castro L, Specht AM, Medeiros GS, Tonietto TF, Mesquita EC, da Silva NB, Korte JE, Hammes LS, Giannini A, Bozza FA, Teixeira C; ICU Visits Study Group Investigators and the Brazilian Research in Intensive Care Network (BRICNet).

JAMA. 2019 Jul 16;322(3):216-228. doi: 10.1001/jama.2019.8766.

PMID:
31310297
4.

An 8-step framework for implementing time-driven activity-based costing in healthcare studies.

da Silva Etges APB, Cruz LN, Notti RK, Neyeloff JL, Schlatter RP, Astigarraga CC, Falavigna M, Polanczyk CA.

Eur J Health Econ. 2019 Jul 8. doi: 10.1007/s10198-019-01085-8. [Epub ahead of print]

PMID:
31286291
5.

DONORS (Donation Network to Optimise Organ Recovery Study): Study protocol to evaluate the implementation of an evidence-based checklist for brain-dead potential organ donor management in intensive care units, a cluster randomised trial.

Westphal GA, Robinson CC, Biasi A, Machado FR, Rosa RG, Teixeira C, de Andrade J, Franke CA, Azevedo LCP, Bozza F, Guterres CM, da Silva DB, Sganzerla D, do Prado DZ, Madalena IC, Rohden AI, da Silva SS, Giordani NE, Andrighetto LV, Benck PS, Roman FR, de Melo MFRB, Pereira TB, Grion CMC, Diniz PC, Oliveira JFP, Mecatti GC, Alves FAC, Moraes RB, Nobre V, Hammes LS, Meade MO, Nothen RR, Falavigna M; DONORS (Donation Network to Optimise Organ Recovery Study) Investigators and the BRICNet.

BMJ Open. 2019 Jun 25;9(6):e028570. doi: 10.1136/bmjopen-2018-028570.

6.

Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis.

Righy C, Rosa RG, da Silva RTA, Kochhann R, Migliavaca CB, Robinson CC, Teche SP, Teixeira C, Bozza FA, Falavigna M.

Crit Care. 2019 Jun 11;23(1):213. doi: 10.1186/s13054-019-2489-3.

7.

Effects of post-ICU follow-up on subject outcomes: A systematic review and meta-analysis.

Rosa RG, Ferreira GE, Viola TW, Robinson CC, Kochhann R, Berto PP, Biason L, Cardoso PR, Falavigna M, Teixeira C.

J Crit Care. 2019 Aug;52:115-125. doi: 10.1016/j.jcrc.2019.04.014. Epub 2019 Apr 11. Review.

PMID:
31035186
8.

Hospital quality indicators: a systematic review.

Breyer JZ, Giacomazzi J, Kuhmmer R, Lima KM, Hammes LS, Ribeiro RA, Kops NL, Falavigna M, Wendland EM.

Int J Health Care Qual Assur. 2019 Mar 11;32(2):474-487. doi: 10.1108/IJHCQA-04-2018-0091.

PMID:
31017060
9.

Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.

Falavigna M, Klitgaard M, Steene E, Flaten GE.

Eur J Pharm Sci. 2019 Apr 30;132:44-54. doi: 10.1016/j.ejps.2019.02.035. Epub 2019 Feb 27.

PMID:
30822502
10.

Users' preferences and perceptions of the comprehensibility and readability of medication labels.

Pons EDS, Moraes CG, Falavigna M, Sirtori LR, da Cruz F, Webster G, Dal Pizzol TDS.

PLoS One. 2019 Feb 22;14(2):e0212173. doi: 10.1371/journal.pone.0212173. eCollection 2019.

11.

Quality of life after intensive care unit: a multicenter cohort study protocol for assessment of long-term outcomes among intensive care survivors in Brazil.

Robinson CC, Rosa RG, Kochhann R, Schneider D, Sganzerla D, Dietrich C, Sanchez ÉC, Dutra FH, Oliveira MQ, Anzolin LB, Menezes SF, Jeffman R, Souza D, Silva SFD, Cruz LN, Boldo R, Cardoso JR, Birriel DC, Gamboa MN, Machado AS, Andrade JMS, Alencar C, Teixeira MC, Vieira SRR, Moreira FC, Amaral A, Silveira APM, Teles JMM, Oliveira DC, Oliveira Júnior LC, Castro LCE, Silva MSD, Neves RT, Gomes RA, Ribeiro CM, Cavalcanti AB, Oliveira RP, Maccari JG, Berto PP, Martins LA, Santos RLDS, Ue LY, Hammes LS, Sharshar T, Bozza F, Falavigna M, Teixeira C.

Rev Bras Ter Intensiva. 2018 Oct-Dec;30(4):405-413. doi: 10.5935/0103-507X.20180063. Epub 2019 Jan 10. Portuguese, English.

12.

Statistical analysis plan for a cluster-randomized crossover trial comparing the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units (the ICU Visits Study).

Sganzerla D, Teixeira C, Robinson CC, Kochhann R, Santos MMS, de Moura RM, Barbosa MG, da Silva DB, Ribeiro T, Eugênio C, Schneider D, Mariani D, Jeffman RW, Bozza F, Cavalcanti AB, Azevedo LCP, Machado FR, Salluh JI, Pellegrini JAS, Moraes RB, Damiani LP, da Silva NB, Falavigna M, Rosa RG.

Trials. 2018 Nov 19;19(1):636. doi: 10.1186/s13063-018-3006-8.

13.

Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis.

Borges Migliavaca C, Stein C, Colpani V, René Pinto de Sousa Miguel S, Nascimento Cruz L, Oliveira Dantas R, Falavigna M.

PLoS Negl Trop Dis. 2018 Sep 28;12(9):e0006836. doi: 10.1371/journal.pntd.0006836. eCollection 2018 Sep.

14.

Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.

Stein C, Migliavaca CB, Colpani V, da Rosa PR, Sganzerla D, Giordani NE, Miguel SRPS, Cruz LN, Polanczyk CA, Ribeiro ALP, Falavigna M.

PLoS Negl Trop Dis. 2018 Aug 20;12(8):e0006742. doi: 10.1371/journal.pntd.0006742. eCollection 2018 Aug.

15.

Development of rapid guidelines: 1. Systematic survey of current practices and methods.

Kowalski SC, Morgan RL, Falavigna M, Florez ID, Etxeandia-Ikobaltzeta I, Wiercioch W, Zhang Y, Sakhia F, Ivanova L, Santesso N, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):61. doi: 10.1186/s12961-018-0327-8.

16.

Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.

Florez ID, Morgan RL, Falavigna M, Kowalski SC, Zhang Y, Etxeandia-Ikobaltzeta I, Santesso N, Wiercioch W, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):62. doi: 10.1186/s12961-018-0329-6.

17.

Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations.

Morgan RL, Florez I, Falavigna M, Kowalski S, Akl EA, Thayer KA, Rooney A, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):63. doi: 10.1186/s12961-018-0330-0.

18.

POP-Brazil study protocol: a nationwide cross-sectional evaluation of the prevalence and genotype distribution of human papillomavirus (HPV) in Brazil.

Wendland EM, Caierão J, Domingues C, Maranhão AGK, de Souza FMA, Hammes LS, Falavigna M, Hilgert JB, Hugo FN, Bessel M, Villa LL, Benzaken AS.

BMJ Open. 2018 Jun 7;8(6):e021170. doi: 10.1136/bmjopen-2017-021170.

19.

Effects of physical exercise after treatment of early breast cancer: systematic review and meta-analysis.

Soares Falcetta F, de Araújo Vianna Träsel H, de Almeida FK, Rangel Ribeiro Falcetta M, Falavigna M, Dornelles Rosa D.

Breast Cancer Res Treat. 2018 Aug;170(3):455-476. doi: 10.1007/s10549-018-4786-y. Epub 2018 Apr 13.

PMID:
29654416
20.

Study protocol to assess the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units: a cluster-randomised, crossover trial (The ICU Visits Study).

Rosa RG, Falavigna M, Robinson CC, da Silva DB, Kochhann R, de Moura RM, Santos MMS, Sganzerla D, Giordani NE, Eugênio C, Ribeiro T, Cavalcanti AB, Bozza F, Azevedo LCP, Machado FR, Salluh JIF, Pellegrini JAS, Moraes RB, Hochegger T, Amaral A, Teles JMM, da Luz LG, Barbosa MG, Birriel DC, Ferraz IL, Nobre V, Valentim HM, Corrêa E Castro L, Duarte PAD, Tregnago R, Barilli SLS, Brandão N, Giannini A, Teixeira C; ICU Visits Study Group Investigators and the BRICNet.

BMJ Open. 2018 Apr 13;8(4):e021193. doi: 10.1136/bmjopen-2017-021193.

21.

Flexible Versus Restrictive Visiting Policies in ICUs: A Systematic Review and Meta-Analysis.

Nassar Junior AP, Besen BAMP, Robinson CC, Falavigna M, Teixeira C, Rosa RG.

Crit Care Med. 2018 Jul;46(7):1175-1180. doi: 10.1097/CCM.0000000000003155.

PMID:
29642108
22.

More than the tip of the iceberg: association between disabilities and inability to attend a clinic-based post-ICU follow-up and how it may impact on health inequalities.

Rosa RG, Kochhann R, Berto P, Biason L, Maccari JG, De Leon P, Dutra F, da Silva SF, Sganzerla D, Schneider D, Cardoso PR, Gomes FK, Machado VH, Medeiros G, Tonietto TF, Tagliari L, Mattioni M, Anzolin L, Oliveira M, de Andrade JMS, Falavigna M, Robinson CC, Teixeira C.

Intensive Care Med. 2018 Aug;44(8):1352-1354. doi: 10.1007/s00134-018-5146-4. Epub 2018 Mar 24. No abstract available.

PMID:
29574573
23.

Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.

Falavigna M, Klitgaard M, Brase C, Ternullo S, Škalko-Basnet N, Flaten GE.

Int J Pharm. 2018 Feb 15;537(1-2):213-222. doi: 10.1016/j.ijpharm.2017.12.038. Epub 2017 Dec 26.

PMID:
29288094
24.

Functional ability in younger and older elderlies after discharge from the intensive care unit. A prospective cohort.

Dietrich C, Cardoso JR, Vargas F, Sanchez EC, Dutra FH, Moreira C, Bessel M, Robinson C, Falavigna M, Teixeira C.

Rev Bras Ter Intensiva. 2017 Jul-Sep;29(3):293-302. doi: 10.5935/0103-507X.20170055. Portuguese, English.

25.

Decision making about healthcare-related tests and diagnostic test strategies. Paper 3: a systematic review shows limitations in most tools designed to assess quality and develop recommendations.

Mustafa RA, Wiercioch W, Falavigna M, Zhang Y, Ivanova L, Arevalo-Rodriguez I, Cheung A, Prediger B, Ventresca M, Brozek J, Santesso N, Bossuyt P, Garg AX, Lloyd N, Lelgemann M, Bühler D, Schünemann HJ.

J Clin Epidemiol. 2017 Dec;92:29-37. doi: 10.1016/j.jclinepi.2017.09.007. Epub 2017 Sep 12. Review.

PMID:
28916490
26.

Effectiveness and Safety of an Extended ICU Visitation Model for Delirium Prevention: A Before and After Study.

Rosa RG, Tonietto TF, da Silva DB, Gutierres FA, Ascoli AM, Madeira LC, Rutzen W, Falavigna M, Robinson CC, Salluh JI, Cavalcanti AB, Azevedo LC, Cremonese RV, Haack TR, Eugênio CS, Dornelles A, Bessel M, Teles JMM, Skrobik Y, Teixeira C; ICU Visits Study Group Investigators.

Crit Care Med. 2017 Oct;45(10):1660-1667. doi: 10.1097/CCM.0000000000002588.

PMID:
28671901
27.

Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial.

Zampieri FG, Azevedo LCP, Corrêa TD, Falavigna M, Machado FR, Assunção MSC, Lobo SMA, Dourado LK, Berwanger O, Kellum JA, Brandão N, Cavalcanti AB; BaSICS Investigators and the BRICNet.

Crit Care Resusc. 2017 Jun;19(2):175-182.

PMID:
28651514
28.

Effects of monochromatic infrared phototherapy in patients with diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials.

Robinson CC, Klahr PDS, Stein C, Falavigna M, Sbruzzi G, Plentz RDM.

Braz J Phys Ther. 2017 Jul - Aug;21(4):233-243. doi: 10.1016/j.bjpt.2017.05.008. Epub 2017 May 20. Review.

29.

Novel in situ gel-forming solid dosage form (gfSDF) prepared by the simple syringe-based moulding: A screening study.

Falavigna M, Škalko-Basnet N, Cavallari C, Pini A, Luppi B, di Cagno MP.

Eur J Pharm Sci. 2017 Jul 15;105:11-18. doi: 10.1016/j.ejps.2017.05.008. Epub 2017 May 5.

PMID:
28483510
30.

Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.

Zhang Y, Coello PA, Brożek J, Wiercioch W, Etxeandia-Ikobaltzeta I, Akl EA, Meerpohl JJ, Alhazzani W, Carrasco-Labra A, Morgan RL, Mustafa RA, Riva JJ, Moore A, Yepes-Nuñez JJ, Cuello-Garcia C, AlRayees Z, Manja V, Falavigna M, Neumann I, Brignardello-Petersen R, Santesso N, Rochwerg B, Darzi A, Rojas MX, Adi Y, Bollig C, Waziry R, Schünemann HJ.

Health Qual Life Outcomes. 2017 May 2;15(1):52. doi: 10.1186/s12955-017-0621-0. Review.

31.

Prevalence of papillomavirus in Brazil: a systematic review protocol.

Colpani V, Bidinotto AB, Falavigna M, Giozza SP, Benzaken AS, Pimenta C, Maranhão AG, Domingues CM, Hammes LS, Wendland EM.

BMJ Open. 2016 Nov 22;6(11):e011884. doi: 10.1136/bmjopen-2016-011884.

32.

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.

Schünemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, Brignardello-Petersen R, Neumann I, Falavigna M, Alhazzani W, Santesso N, Zhang Y, Meerpohl JJ, Morgan RL, Rochwerg B, Darzi A, Rojas MX, Carrasco-Labra A, Adi Y, AlRayees Z, Riva J, Bollig C, Moore A, Yepes-Nuñez JJ, Cuello C, Waziry R, Akl EA.

J Clin Epidemiol. 2017 Jan;81:101-110. doi: 10.1016/j.jclinepi.2016.09.009. Epub 2016 Oct 3.

33.

The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels.

Neumann I, Brignardello-Petersen R, Wiercioch W, Carrasco-Labra A, Cuello C, Akl E, Mustafa RA, Al-Hazzani W, Etxeandia-Ikobaltzeta I, Rojas MX, Falavigna M, Santesso N, Brozek J, Iorio A, Alonso-Coello P, Schünemann HJ.

Implement Sci. 2016 Jul 15;11:93. doi: 10.1186/s13012-016-0462-y.

34.

Factors influencing decline of physical functional status among icu survivors: a prospective cohort study.

Oliveira R, Rosa R, Ascoli A, Rutzen W, Madeira L, Ghizzoni F, Khummer R, Vargas F, Lago L, Dietrich C, Ceron C, Guterres C, Vesz P, Schaefer A, Falavigna M, Lima K, Robinson C, Ribeiro R, Maccari J, Teixeira C.

Intensive Care Med Exp. 2015 Dec;3(Suppl 1):A361. doi: 10.1186/2197-425X-3-S1-A361. No abstract available.

35.

Risk factors for hyperactive delirium among icu adult patients in southern brazil: a prospective cohort study.

Oliveira R, Rosa R, Ascoli A, Rutzen W, Madeira L, Balzano P, Morandi P, Souto V, Vargas F, Lago L, Dietrich C, Rezende J, Ghizzoni F, Souza MC, Guterres C, Falavigna M, Lima K, Robinson C, Ribeiro R, Maccari J, Teixeira C.

Intensive Care Med Exp. 2015 Dec;3(Suppl 1):A331. doi: 10.1186/2197-425X-3-S1-A331. No abstract available.

36.

Effectiveness of pharmaceutical care at discharge in the emergency department: study protocol of a randomized controlled trial.

Kuhmmer R, Lima KM, Ribeiro RA, Hammes LS, Bastos GA, Cotta de Souza MC, Polanczyk CA, Soares Rollin GA, Caon S, Guterres CM, Araújo Leite LE, Delabary TS, Falavigna M.

Trials. 2015 Feb 25;16:60. doi: 10.1186/s13063-015-0579-3.

37.

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.

Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, Wolff R, Kujpers T, Perel P, Vandvik PO, Glasziou P, Schunemann H, Guyatt G.

BMJ. 2015 Mar 16;350:h870. doi: 10.1136/bmj.h870. No abstract available.

38.

Impact of the International Association of Diabetes and Pregnancy Study Groups criteria for gestational diabetes.

Trujillo J, Vigo A, Duncan BB, Falavigna M, Wendland EM, Campos MA, Schmidt MI.

Diabetes Res Clin Pract. 2015 May;108(2):288-95. doi: 10.1016/j.diabres.2015.02.007. Epub 2015 Feb 21.

PMID:
25765668
39.

The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity.

Al-Hameed F, Al-Dorzi HM, Shamy A, Qadi A, Bakhsh E, Aboelnazar E, Abdelaal M, Al Khuwaitir T, Al-Moamary MS, Al-Hajjaj MS, Brozek J, Schünemann H, Mustafa R, Falavigna M.

Ann Thorac Med. 2015 Jan-Mar;10(1):3-15. doi: 10.4103/1817-1737.146849.

40.

Effects of lifestyle modification after breast cancer treatment: a systematic review protocol.

Falavigna M, Lima KM, Giacomazzi J, Paskulin Dd, Hammes LS, Ribeiro RA, Rosa DD.

Syst Rev. 2014 Jul 5;3:72. doi: 10.1186/2046-4053-3-72.

41.

Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy.

Colagiuri S, Falavigna M, Agarwal MM, Boulvain M, Coetzee E, Hod M, Meltzer SJ, Metzger B, Omori Y, Rasa I, Schmidt MI, Seshiah V, Simmons D, Sobngwi E, Torloni MR, Yang HX.

Diabetes Res Clin Pract. 2014 Mar;103(3):364-72. doi: 10.1016/j.diabres.2014.02.012. Epub 2014 Feb 25.

PMID:
24731475
42.

Methodological survey of designed uneven randomization trials (DU-RANDOM): a protocol.

Wu D, Akl EA, Guyatt GH, Devereaux PJ, Brignardello-Petersen R, Prediger B, Patel K, Patel N, Lu T, Zhang Y, Falavigna M, Santesso N, Mustafa RA, Zhou Q, Briel M, Schünemann HJ.

Trials. 2014 Jan 23;15:33. doi: 10.1186/1745-6215-15-33.

43.

Efficacy of vitamin D supplementation in depression in adults: a systematic review.

Li G, Mbuagbaw L, Samaan Z, Falavigna M, Zhang S, Adachi JD, Cheng J, Papaioannou A, Thabane L.

J Clin Endocrinol Metab. 2014 Mar;99(3):757-67. doi: 10.1210/jc.2013-3450. Epub 2013 Dec 11. Review.

44.

Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.

Schünemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, Ventresca M, Brignardello-Petersen R, Laisaar KT, Kowalski S, Baldeh T, Zhang Y, Raid U, Neumann I, Norris SL, Thornton J, Harbour R, Treweek S, Guyatt G, Alonso-Coello P, Reinap M, Brozek J, Oxman A, Akl EA.

CMAJ. 2014 Feb 18;186(3):E123-42. doi: 10.1503/cmaj.131237. Epub 2013 Dec 16.

45.

Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients.

Péres DP, Cheinquer H, Wolf FH, Cheinquer N, Falavigna M, Péres LD.

Ann Hepatol. 2013 Nov-Dec;12(6):871-5.

46.

Tissue microarray design and construction for scientific, industrial and diagnostic use.

Pilla D, Bosisio FM, Marotta R, Faggi S, Forlani P, Falavigna M, Biunno I, Martella E, De Blasio P, Borghesi S, Cattoretti G.

J Pathol Inform. 2012;3:42. doi: 10.4103/2153-3539.104904. Epub 2012 Dec 20.

47.

Impact of gestational diabetes mellitus screening strategies on perinatal outcomes: a simulation study.

Falavigna M, Prestes I, Schmidt MI, Duncan BB, Colagiuri S, Roglic G.

Diabetes Res Clin Pract. 2013 Mar;99(3):358-65. doi: 10.1016/j.diabres.2012.12.009. Epub 2013 Jan 15.

PMID:
23332050
48.

Cell and tissue microarray technologies for protein and nucleic acid expression profiling.

Cardano M, Diaferia GR, Falavigna M, Spinelli CC, Sessa F, DeBlasio P, Biunno I.

J Histochem Cytochem. 2013 Feb;61(2):116-24. doi: 10.1369/0022155412470455. Epub 2012 Nov 19.

49.

Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment.

Falavigna M, Schmidt MI, Trujillo J, Alves LF, Wendland ER, Torloni MR, Colagiuri S, Duncan BB.

Diabetes Res Clin Pract. 2012 Dec;98(3):396-405. doi: 10.1016/j.diabres.2012.09.002. Epub 2012 Sep 29. Review.

PMID:
23031412
50.

Gestational diabetes and pregnancy outcomes--a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria.

Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, Duncan BB, Schmidt MI.

BMC Pregnancy Childbirth. 2012 Mar 31;12:23. doi: 10.1186/1471-2393-12-23. Review.

Supplemental Content

Loading ...
Support Center